Telehealth and home care services face potential disruptions, impacting rural and mobility-limited patients, with possible ...

Medicare beneficiaries face confusion in selecting plans, with 75% finding the process challenging and many unaware of ...

Despite an executive order aimed at addressing homelessness in the US, defunding vital programs could spell difficulty in helping the homeless.

Compared with SNRA, SPRA was linked to a 29% higher risk of pneumonia and a 58% higher risk of hospitalization. Researchers noted that seropositivity may reflect greater systemic inflammation and ...

An expert discusses how current ITP treatments like corticosteroids, rituximab, and fostamatinib have significant tolerability issues and fail to provide sustained platelet responses or address ...

A key barrier in advancing care for ROS1-positive non-small cell lung cancer (NSCLC) is the rarity of the condition, affecting only about 1.5% to 2% of patients. While this still represents a notable ...

AJMC: Osimertinib is an oral drug, whereas amivantamab is an intravenous formulation. Given those differences in delivery mechanisms, how do physicians need to change up workflows for the ...

Several actions taken by the current administration may affect the landscape of prevention of HIV, prompting an analysis of these effects.

At the European Respiratory Society Congress 2025, Lucilla Piccari, MD, PhD, a pulmonologist at Hospital del Mar in Barcelona, Spain, discussed the profound impact of social inequality, environmental ...

Timothy W. Cutler, PharmD, associate chief of ambulatory care at UC Davis Health, describes how pharmacy services patients healthy and out of the hospital.

An expert discusses how rilzabrutinib, a recently FDA-approved Bruton tyrosine kinase inhibitor, targets the autoimmune pathophysiology of ITP by modulating B cells, macrophages, and reducing ...

Although multiple myeloma is often considered incurable, the development of highly effective new therapies is creating a real possibility of a cure for some patients. Current 4-drug upfront regimens, ...